Lead Scientist, Translational Biology Immunology

Nxera Pharma
Cambridge
1 month ago
Create job alert

CK Group are working in partnership with Nxera Pharma to recruit a Lead Scientist, Translational Biology Immunology, to join their Translational Biology Immunology and Metabolism group.


The ideal candidate will have a strong track record of project leadership, CRO management, expertise in planning and executing preclinical target validation, and translational studies to support project deliverables.



Location:

Granta Park, Cambridge.



About the company:

Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new speciality medicines to improve the lives of patients with unmet needs globally. Their pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across CNS, GI and immunology, metabolic disorders and rare diseases, and leverages the power of their unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates.

In Cambridge UK, Nxera have built outstanding capabilities across their platform, discovery and translational medicine teams, to advance multiple programs from pre-clinical through to early clinical development.



About the role:

This is an exciting opportunity to work across diverse functional groups within Nxera Pharma and with external industrial and academic collaborators. The Translational Biology Team is a multidisciplinary team focused on understanding the mechanisms underlying human disease biology.

The ideal candidate will be passionate about advancing novel therapies, and biomarker strategies for the treatment of immune disorders.



Responsibilities will include:

  • Leading, executing and driving new Target Identification and Validation initiatives.
  • Ensuring a robust translational framework is embedded early in the project lifetime to drive clear decision making in the clinic.
  • Oversee the development and optimisation of functional immunology assays at CROs.
  • Depending on experience, may act as the Project Translational lead.



Skills and Experience:

  • PhD with demonstrable drug discovery or development experience or BSc with demonstrable drug discovery or development experience in immunology projects.
  • Extensive experience in the planning, analysis, and interpretation of in vitro and in vivo target validation and translational studies for immunological targets.
  • Proven technical knowledge in interrogating complex immunological mechanisms using a range of in vitro and ex vivo immunological assays (e.g. isolated leukocyte subset functional assays, flow cytometry, RNA expression analysis, biochemical signalling, MSD/ELISA, imaging).
  • Strong track record in human and rodent primary immune cell assay development and optimisation.
  • Good understanding of Home Office legislation governing in vivo research and direct experience in the experimental design and oversight of in vivo studies.
  • Proven ability in data analysis and problem-solving, skilled at delivering decision-making data.
  • Proven ability to work effectively in a fast paced, multidisciplinary matrix team environment.
  • Excellent interpersonal, communication and presentation skills and ability to thrive in team setting.
  • Experience of carrying out both independent and collaborative research.




Desirable:

  • Hands-on experience in managing outsourced studies with CROs or academic partners.
  • Project leadership experience within a biotech or pharma setting, alternatively if coming from an academic background experience working in industry collaborations would be beneficial.
  • A strong background in translational research and proven ability to plan and execute translational strategies to support decision making in clinical studies.



What’s in it for you?

  • State-of-the-art R&D centre located in the heart of the Cambridge science cluster.
  • Competitive compensation package including discretionary cash bonuses.
  • Eligible for grants of Restricted Stock Units.
  • 26 days annual leave in addition to public holidays plus the option to purchase an additional 5 days each year.
  • Employer contribution to pension.
  • Private Medical Insurance for employees and family and a cash plan for dental and optical reimbursement.
  • Health and wellbeing benefits including a subsidised individual gym membership.
  • Income protection to cover long term absences due to ill health.
  • Group Death in Service equal to 4x basic annual salary.



Apply:

Please quote job reference 123 438 in all correspondence.

Related Jobs

View all jobs

Principal Scientist - Biomarkers & Proteomics

Service Owner - Scientific Research

Lead Scientist

R&D Scientist

Lead Data Scientist

Lead Data Scientist

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Contract vs Permanent Biotech Jobs: Which Pays Better in 2025?

In the ever-advancing world of life sciences, biotechnology has emerged as one of the fastest-growing and most impactful sectors in the UK. From gene editing and regenerative medicine to synthetic biology and vaccine development, British biotech organisations are at the forefront of scientific innovation. With this growth comes a high demand for skilled professionals—scientists, data analysts, regulatory affairs specialists, bioprocess engineers, and more—who can help bring cutting-edge treatments and products to market. However, as the biotechnology landscape in the UK continues to expand, so too do the ways in which professionals choose to work. Beyond traditional permanent employment, many biotech specialists are exploring the world of contracting, which can take the form of day‑rate consulting or fixed-term contracts (FTC). Each path promises unique advantages and disadvantages, from pay rates and benefits packages to career development and job security. This article offers a comprehensive guide on contract vs. permanent biotech jobs in 2025. We will explore how the UK biotech sector is shaping up, break down the different types of employment arrangements, and present sample take‑home pay scenarios for each. Our goal is to empower you with the knowledge needed to make an informed decision that aligns with both your financial aspirations and long-term career goals within the vibrant and evolving biotech industry.

Biotech Jobs for Non‑Technical Professionals: Where Do You Fit In?

Your Place in Britain’s Biotech Boom When most people picture biotechnology careers they imagine pipettes, petri dishes and white‑coated scientists in Cambridge or Oxford. Yet for every bench scientist there is an ecosystem of professionals who never set foot in the lab but are crucial to getting a therapy, diagnostic or food‑tech breakthrough to market. The UK BioIndustry Association (BIA) reports that non‑scientific vacancies now make up more than one‑third of all biotech job ads, and demand is accelerating. According to Vacancysoft’s Life Sciences Labour Market Trends (November 2024), biotech job postings in the Golden Triangle jumped 26 % year‑on‑year, with hotspots also emerging in Birmingham and Glasgow. Finance is following suit: the sector attracted £3.5 billion in investment during 2024, a 94 % rebound from 2023 levels. More capital means more hires in project management, regulatory affairs, and commercial operations. In short, biotech is not just for PhDs, and you don’t need to master CRISPR to make an impact. This guide explains the high‑growth, non‑technical roles; the transferable skills you already possess; real‑life transition stories; and a step‑by‑step plan to pivot into the UK’s most exciting industry.

Johnson & Johnson Biotech Jobs in 2025: Your Complete UK Guide to Joining the World’s Largest Healthcare Innovator

From the first mass‑produced sterile surgical dressings in the 1880s to first‑in‑class CAR‑T cell therapies in the 2020s, Johnson & Johnson (J&J) has continuously re‑invented healthcare. Following the 2024 spin‑off of its consumer division (Kenvue) and the rebrand of Janssen to Johnson & Johnson Innovative Medicine, the company now focuses squarely on pharmaceutical innovation, med‑tech and vision care. With revenues exceeding US $90 bn and a pipeline spanning oncology, immunology, vaccines and digital surgery, J&J remains a magnet for biotech talent. A quick scan of the Johnson & Johnson careers portal shows over 2,000 open roles in EMEA, with nearly 300 in the UK, across R&D, manufacturing, clinical affairs and data science. This guide explains how to land a Johnson & Johnson biotech job in 2025—from graduate scientist to principal data engineer.